Annual report
3055.TEDINET S100OAHB
Period2021-04-01 → 2022-03-31
Filed2022-06-30
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥248.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥239.5bn | 2020-04-01 → 2021-03-31 | Cons. | Net sales |
| Revenue | ¥243.1bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥235.2bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥227.8bn | 2017-04-01 → 2018-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥2.1bn | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Operating income | ¥1.4bn | 2020-04-01 → 2021-03-31 | Cons. | Operating income |
| Ordinary income | ¥3.4bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.7bn | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥4.1bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.5bn | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.5bn | 2017-04-01 → 2018-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥3.8bn | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥2.5bn | 2020-04-01 → 2021-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.8bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.5bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.0bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.1bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.2bn | 2017-04-01 → 2018-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥2.8bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Net income | ¥1.5bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss |
| Total assets | ¥136.9bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥133.0bn | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥130.7bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥125.1bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥123.4bn | at 2018-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥81.3bn | at 2022-03-31 | Cons. | Liabilities |
| Total liabilities | ¥78.6bn | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥55.5bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥54.4bn | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥52.7bn | at 2020-03-31d | Cons. | Net assets |
| Net assets / equity | ¥51.1bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥49.3bn | at 2018-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥21.1bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥20.4bn | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥21.1bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥20.4bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥21.6bn | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥20.9bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥20.7bn | at 2018-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥3.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.8bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥4.7bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.6bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥5.7bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥1.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.2bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥3.7bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.9bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.7bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥849m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥731m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥444m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥530m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.2bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥123.44 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥64.01 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥86.81 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥88.96 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥89.14 | 2017-04-01 → 2018-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2,460.67 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,346.36 | at 2021-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,239.8 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,170.74 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,085.06 | at 2018-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 40.6% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.9% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.4% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.9% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.9% | at 2018-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 5.1% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 2.8% | 2020-04-01 → 2021-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.9% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.2% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.5% | 2017-04-01 → 2018-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,625 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 1,570 | at 2021-03-31 | Cons. | Number of employees |
| Employees | 1,485 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 1,441 | at 2019-03-31d | Cons. | Number of employees |
| Employees | 1,426 | at 2018-03-31d | Cons. | Number of employees |
| Revenue | ¥1.3bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥1.8bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥1.6bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥6.7bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.0bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥174m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | ¥741m | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥289m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥785m | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥605m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥5.3bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥908m | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥648m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥641m | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥619m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥637m | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | ¥204m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥5.3bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥904m | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥44.5bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥44.6bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥40.3bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥40.4bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥35.6bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.6bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.6bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥42.9bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥43.1bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥40.0bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥40.2bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥35.4bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.9bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.3bn | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥27.27 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.33 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.7 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥225.79 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.32 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥17 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥15 | 2020-04-01 → 2021-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥17 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥17 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥17 | 2017-04-01 → 2018-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,900.56 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,859.64 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,701.04 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,709.32 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,497.19 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 96.5% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 96.5% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 99.4% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 99.5% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 99.3% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 1.4% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.5% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 0.5% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.1% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.5% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 24,400,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 24,400,000 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 24,400,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 24,400,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 24,400,000 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 62 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 62 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 53 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 57 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 59 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 89
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | depreciation | 2021-04-01 → 2022-03-31 | ¥44m |
| Otherother segments | revenue | 2021-04-01 → 2022-03-31 | ¥1.5bn |
| Otherother segments | revenue external | 2021-04-01 → 2022-03-31 | ¥58m |
| Otherother segments | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥1.5bn |
| Otherother segments | segment assets | at 2022-03-31 | ¥44.6bn |
| Otherother segments | segment profit | 2021-04-01 → 2022-03-31 | ¥179m |
| Dispensing Industryreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥93m |
| Dispensing Industryreportable segment | employees | at 2022-03-31 | 323 pure |
| Dispensing Industryreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥13.7bn |
| Dispensing Industryreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥13.7bn |
| Dispensing Industryreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥13m |
| Dispensing Industryreportable segment | segment assets | at 2022-03-31 | ¥6.4bn |
| Dispensing Industryreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥159m |
| Information And Communication Technology Industryreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥19m |
| Information And Communication Technology Industryreportable segment | employees | at 2022-03-31 | 76 pure |
| Information And Communication Technology Industryreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥1.5bn |
| Information And Communication Technology Industryreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥522m |
| Information And Communication Technology Industryreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥961m |
| Information And Communication Technology Industryreportable segment | segment assets | at 2022-03-31 | ¥894m |
| Information And Communication Technology Industryreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥90m |
| Medical Equipment Wholesale Industryreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥256m |
| Medical Equipment Wholesale Industryreportable segment | employees | at 2022-03-31 | 409 pure |
| Medical Equipment Wholesale Industryreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥62.3bn |
| Medical Equipment Wholesale Industryreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥61.8bn |
| Medical Equipment Wholesale Industryreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥471m |
| Medical Equipment Wholesale Industryreportable segment | segment assets | at 2022-03-31 | ¥25.2bn |
| Medical Equipment Wholesale Industryreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥1.2bn |
| Nursing Industryreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥173m |
| Nursing Industryreportable segment | employees | at 2022-03-31 | 254 pure |
| Nursing Industryreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥3.8bn |
| Nursing Industryreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥3.8bn |
| Nursing Industryreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥10m |
| Nursing Industryreportable segment | segment assets | at 2022-03-31 | ¥4.7bn |
| Nursing Industryreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥348m |
| Wholesaler Of Drugs Industryreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥493m |
| Wholesaler Of Drugs Industryreportable segment | employees | at 2022-03-31 | 488 pure |
| Wholesaler Of Drugs Industryreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥177.2bn |
| Wholesaler Of Drugs Industryreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥168.5bn |
| Wholesaler Of Drugs Industryreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥8.7bn |
| Wholesaler Of Drugs Industryreportable segment | segment assets | at 2022-03-31 | ¥91.6bn |
| Wholesaler Of Drugs Industryreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥582m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥260.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥248.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥11.7bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥173.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥2.6bn |
| Otherother segments | depreciation | 2020-04-01 → 2021-03-31 | ¥35m |
| Otherother segments | revenue | 2020-04-01 → 2021-03-31 | ¥2.0bn |
| Otherother segments | revenue external | 2020-04-01 → 2021-03-31 | ¥53m |
| Otherother segments | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥1.9bn |
| Otherother segments | segment assets | at 2021-03-31 | ¥44.8bn |
| Otherother segments | segment profit | 2020-04-01 → 2021-03-31 | ¥747m |
| Dispensing Industryreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥103m |
| Dispensing Industryreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥13.8bn |
| Dispensing Industryreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥13.8bn |
| Dispensing Industryreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥13m |
| Dispensing Industryreportable segment | segment assets | at 2021-03-31 | ¥6.3bn |
| Dispensing Industryreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥130m |
| Information And Communication Technology Industryreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥23m |
| Information And Communication Technology Industryreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥1.7bn |
| Information And Communication Technology Industryreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥466m |
| Information And Communication Technology Industryreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥1.2bn |
| Information And Communication Technology Industryreportable segment | segment assets | at 2021-03-31 | ¥801m |
| Information And Communication Technology Industryreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥150m |
| Medical Equipment Wholesale Industryreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥277m |
| Medical Equipment Wholesale Industryreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥60.9bn |
| Medical Equipment Wholesale Industryreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥60.1bn |
| Medical Equipment Wholesale Industryreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥748m |
| Medical Equipment Wholesale Industryreportable segment | segment assets | at 2021-03-31 | ¥25.9bn |
| Medical Equipment Wholesale Industryreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥751m |
| Nursing Industryreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥163m |
| Nursing Industryreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥3.8bn |
| Nursing Industryreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥3.7bn |
| Nursing Industryreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥36m |
| Nursing Industryreportable segment | segment assets | at 2021-03-31 | ¥4.6bn |
| Nursing Industryreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥379m |
| Wholesaler Of Drugs Industryreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥536m |
| Wholesaler Of Drugs Industryreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥169.9bn |
| Wholesaler Of Drugs Industryreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥161.3bn |
| Wholesaler Of Drugs Industryreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥8.6bn |
| Wholesaler Of Drugs Industryreportable segment | segment assets | at 2021-03-31 | ¥87.9bn |
| Wholesaler Of Drugs Industryreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥374m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-04-01 → 2021-03-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-04-01 → 2021-03-31 | ¥252.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-04-01 → 2021-03-31 | ¥239.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥12.6bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-03-31 | ¥170.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-04-01 → 2021-03-31 | ¥2.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,756
| Item | Context | Value | Unit |
|---|---|---|---|
| Total assets (5-year summary) | Prior2YearInstant | 130653000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 132955000000 | JPY |
| Total assets (5-year summary) | CurrentYearInstant | 136883000000 | JPY |
| Net assets per share (5-year summary) | Prior4YearInstant | 2085.06 | |
| Net assets per share (5-year summary) | Prior3YearInstant | 2170.74 | |
| Net assets per share (5-year summary) | Prior2YearInstant | 2239.80 | |
| Net assets per share (5-year summary) | Prior1YearInstant | 2346.36 | |
| Net assets per share (5-year summary) | CurrentYearInstant | 2460.67 | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration | 89.14 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration | 88.96 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration | 86.81 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 64.01 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration | 123.44 | |
| Diluted earnings per share (5-year summary) | Prior4YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior4YearInstant | 0.3994 | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant | 0.4086 | |
| Equity to asset ratio (5-year summary) | Prior2YearInstant | 0.4035 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.4089 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant | 0.4057 | |
| Rate of return on equity (5-year summary) | Prior4YearDuration | 0.0447 | |
| Rate of return on equity (5-year summary) | Prior3YearDuration | 0.0418 | |
| Rate of return on equity (5-year summary) | Prior2YearDuration | 0.0394 | |
| Rate of return on equity (5-year summary) | Prior1YearDuration | 0.0279 | |
| Rate of return on equity (5-year summary) | CurrentYearDuration | 0.0510 | |
| Price earnings ratio (5-year summary) | Prior4YearDuration | 9.48 | |
| Price earnings ratio (5-year summary) | Prior3YearDuration | 8.61 | |
| Price earnings ratio (5-year summary) | Prior2YearDuration | 8.19 | |
| Price earnings ratio (5-year summary) | Prior1YearDuration | 11.79 | |
| Price earnings ratio (5-year summary) | CurrentYearDuration | 5.35 | |
| Net cash provided by used in operating activities (5-year summary) | Prior4YearDuration | 5741000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior3YearDuration | 2613000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior2YearDuration | 4745000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 1791000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYearDuration | 3166000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior4YearDuration | -1696000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior3YearDuration | -1862000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior2YearDuration | -3662000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -2179000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYearDuration | -1659000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior4YearDuration | -1165000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior3YearDuration | -530000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior2YearDuration | -444000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -731000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYearDuration | -849000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior4YearInstant | 20693000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior3YearInstant | 20913000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |